National Cancer Institute, Bethesda, MD. SEER cancer stat facts: pancreatic cancer. https://seer.cancer.gov/statfacts/html/pancreas.html.

Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Pineros M, et al. Global cancer observatory: cancer tomorrow [Internet]. 2018. https://gco.iarc.fr/tomorrow.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Article  PubMed  Google Scholar 

Gordon-Dseagu VL, Devesa SS, Goggins M, Stolzenberg-Solomon R. Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data. Int J Epidemiol. 2018;47:427–39.

Article  PubMed  Google Scholar 

Yachida S, Jones S, Bozic I, Antal T, Leary R, Fu B, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010;467:1114–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fahy E, Cotter D, Sud M, Subramaniam S. Lipid classification, structures and tools. Biochim Biophys Acta. 2011;1811:637–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang R, Li B, Lam SM, Shui G. Integration of lipidomics and metabolomics for in-depth understanding of cellular mechanism and disease progression. J Genet Genom Yi Chuan Xue Bao. 2020;47:69–83.

Article  Google Scholar 

Heimerl S, Fischer M, Baessler A, Liebisch G, Sigruener A, Wallner S, et al. Alterations of plasma lysophosphatidylcholine species in obesity and weight loss. PLoS ONE. 2014;9: e111348.

Article  PubMed  PubMed Central  Google Scholar 

Fernandez C, Surma MA, Klose C, Gerl MJ, Ottosson F, Ericson U, et al. Plasma lipidome and prediction of type 2 diabetes in the population-based Malmö diet and cancer cohort. Diabetes Care. 2020;43:366–73.

Article  CAS  PubMed  Google Scholar 

Eichelmann F, Sellem L, Wittenbecher C, Jäger S, Kuxhaus O, Prada M, et al. Deep lipidomics in human plasma—cardiometabolic disease risk and effect of dietary fat modulation. Circulation. 2022;146:21–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18:493–592.

Article  PubMed  PubMed Central  Google Scholar 

WCRF/AICR. World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Alcoholic drinks and the risk of cancer [Internet]. WCRF/AICR; 2018. dietandcancerreport.org.

Thiébaut ACM, Jiao L, Silverman DT, Cross AJ, Thompson FE, Subar AF, et al. Dietary fatty acids and pancreatic cancer in the NIH-AARP diet and health study. J Natl Cancer Inst. 2009;101:1001–11.

Article  PubMed  PubMed Central  Google Scholar 

Zhou D, Mu D, Cheng M, Dou Y, Zhang X, Feng Z, et al. Differences in lipidomics may be potential biomarkers for early diagnosis of pancreatic cancer. Acta Cir Bras. 2020;35: e202000508.

Article  PubMed  PubMed Central  Google Scholar 

Gaiser RA, Pessia A, Ateeb Z, Davanian H, Fernández Moro C, Alkharaan H, et al. Integrated targeted metabolomic and lipidomic analysis: a novel approach to classifying early cystic precursors to invasive pancreatic cancer. Sci Rep. 2019;9:10208.

Article  PubMed  PubMed Central  Google Scholar 

Tao L, Zhou J, Yuan C, Zhang L, Li D, Si D, et al. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer. Metabol Off J Metab Soc. 2019;15:86.

Google Scholar 

Wolrab D, Jirásko R, Cífková E, Höring M, Mei D, Chocholoušková M, et al. Lipidomic profiling of human serum enables detection of pancreatic cancer. Nat Commun. 2022;13:124.

Article  CAS  PubMed  PubMed Central  Google Scholar 

The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol. 1994;4:1–10.

Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21:273S-309S.

Article  CAS  PubMed  Google Scholar 

Andriole GL, Crawford ED, Grubb RL, Buys SS, Chia D, Church TR, et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012;104:125–32.

Article  PubMed  PubMed Central  Google Scholar 

Korhonen P, Malila N, Pukkala E, Teppo L, Albanes D, Virtamo J. The Finnish Cancer Registry as follow-up source of a large trial cohort–accuracy and delay. Acta Oncol Stockh Swed. 2002;41:381–8.

Article  Google Scholar 

Löfgren L, Ståhlman M, Forsberg G-B, Saarinen S, Nilsson R, Hansson GI. The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. J Lipid Res. 2012;53:1690–700.

Article  PubMed  PubMed Central  Google Scholar 

Fay MP, Graubard BI, Freedman LS, Midthune DN. Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics. 1998;54:195–208.

Article  CAS  PubMed  Google Scholar 

Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1–48. https://doi.org/10.18637/jss.v036.i03.

Article  Google Scholar 

Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res. 2001;125:279–84.

Article  CAS  PubMed  Google Scholar 

Bodenhofer U. PODKAT: an R package for association testing involving rare and private variants. 2021. http://www.bioinf.jku.at/software/podkat/.

Tibshirani R. Regression shrinkage and selection via the Lasso. J R Stat Soc Ser B Methodol. 1996;58:267–88.

Google Scholar 

Tibshirani R. Regression shrinkage and selection via the lasso: a retrospective. J R Stat Soc Ser B Stat Methodol. 2011;73:273–82. https://doi.org/10.1111/j.1467-9868.2011.00771.x.

Article  Google Scholar 

Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):22.

Article  Google Scholar 

Yuan C, Kim J, Wang QL, Lee AA, Babic A, PanScan/PanC4 I-III Consortium, et al. The age-dependent association of risk factors with pancreatic cancer. Ann Oncol Off J Eur Soc Med Oncol. 2022;33:693–701.

Article  CAS  Google Scholar 

Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nat Commun. 2018;9:556.

Article  PubMed  PubMed Central  Google Scholar 

R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2020. https://www.R-project.org/.

Martín-Blázquez A, Jiménez-Luna C, Díaz C, Martínez-Galán J, Prados J, Vicente F, et al. Discovery of pancreatic adenocarcinoma biomarkers by untargeted metabolomics. Cancers. 2020;12:1002.

Article  PubMed  PubMed Central  Google Scholar 

Ritchie SA, Akita H, Takemasa I, Eguchi H, Pastural E, Nagano H, et al. Metabolic system alterations in pancreatic cancer patient serum: potential for early detection. BMC Cancer. 2013;13:416.

Article  PubMed  PubMed Central  Google Scholar 

Urayama S, Zou W, Brooks K, Tolstikov V. Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun Mass Spectrom RCM. 2010;24:613–20.

Article  CAS  PubMed  Google Scholar 

Mehta KY, Wu H-J, Menon SS, Fallah Y, Zhong X, Rizk N, et al. Metabolomic biomarkers of pancreatic cancer: a meta-analysis study. Oncotarget. 2017;8:68899–915.

Article  PubMed  PubMed Central  Google Scholar 

Di Gangi IM, Mazza T, Fontana A, Copetti M, Fusilli C, Ippolito A, et al. Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites. Oncotarget. 2016;7:5815–29.

Article  PubMed  PubMed Central  Google Scholar 

Liu P, Zhu W, Chen C, Yan B, Zhu L, Chen X, et al. The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sci. 2020;247: 117443.

Article  CAS  PubMed  Google Scholar 

Breeur M, Ferrari P, Dossus L, Jenab M, Johansson M, Rinaldi S, et al. Pan-cancer analysis of pre-diagnostic blood metabolite concentrations in the European prospective investigation into cancer and nutrition. BMC Med. 2022;20:351.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barber MN, Risis S, Yang C, Meikle PJ, Staples M, Febbraio MA, et al. Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. PLoS ONE. 2012;7: e41456.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Jiang C-T, Song J-Y, Song Q-Y, Ma J, Wang H-J. Lipidomic profile revealed the association of plasma lysophosphatidylcholines with adolescent obesity. BioMed Res Int. 2019;2019:1382418.

Article  PubMed  PubMed Central  Google Scholar 

Floegel A, Stefan N, Yu Z, Mühlenbruch K, Drogan D, Joost H-G, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62:639–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, et